New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine. - Wikidata - awgldk - TriplyDB

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

http://www.wikidata.org/entity/Q34715598

about

The blind men and the AML elephant: can we feel the progress?Targeting cell cycle regulators in hematologic malignancies.Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia.Targeting novel signaling pathways for resistant acute myeloid leukemia.Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes.A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!

P2860

Q26749614-8D1FA698-BAD0-4D44-B802-45CB5CBE3170 Q35334436-0565EBDE-9F3C-484F-9DA3-DF904AEFD3F1 Q36925443-B7BC31E9-78BA-4C78-85B3-A74F97503C6F Q38297507-4D650978-69FF-4F99-9A4A-1725B02B580F Q38882048-FCCBF25C-F2D6-435A-AE92-9992D5432AE8 Q39510346-8C80FC8E-DCB0-4D7E-9728-67E994EF59E5 Q47289766-586B269F-393A-4DDC-828A-5C8B5D3A4397

P2860

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

http://www.wikidata.org/entity/Q34715598

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@ast

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@en

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@nl

type

label

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@ast

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@en

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@nl

prefLabel

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@ast

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@en

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@nl

P1433

Q34715598-03A3F662-ECCD-49A3-B962-CDF51EF11C6A

P1476

Q34715598-03CA47EF-543B-4540-B6F7-6FAEDE027CB8

P2093

Q34715598-AF8451A6-1248-46A9-A367-DA68B1E35185

Q34715598-FA48FBD2-7FC1-4C72-8A34-B1EF8D5D3DF1

P2860

Q34715598-01D1DCE5-32AB-4263-B894-99A50B04155E

Q34715598-0660EAEF-4B7E-40A8-B8CA-1B29B12A96E0

Q34715598-0DFEA233-A46D-4178-815C-047650332086

Q34715598-113E77EF-A69B-4660-9CED-9C348BA88B57

Q34715598-1984CC78-20BB-47E4-97FF-5606AE5B9131

Q34715598-1B0CE4C9-F0D9-42D5-AB5D-63899473F3BB

Q34715598-1D2F251E-59D3-4F81-9C27-CDA958909925

Q34715598-20A84A22-7E33-4306-8360-C63409F82A36

Q34715598-218351D3-F5F1-4605-9A0B-6D1EBA6EF055

Q34715598-24DC9BA2-2BD1-476D-8B76-EA07D537EF0C

P304

Q34715598-19EB913C-D3A4-44F7-B52C-F56D67F48A97

P31

Q34715598-E39569B4-2738-4040-99A3-8F87007D72BA

P356

Q34715598-225294C9-10BC-4DBE-9CAD-230AA7D09E86

P407

Q34715598-EAC4820A-AA79-464E-B4B1-55F7A8503E03

P433

Q34715598-C6A1BA13-C7C9-429D-B6FA-9485D9D3150A

P478

Q34715598-D2B6C7AA-3F45-4794-A923-6CC6DD7E4A65

P577

Q34715598-E9BC02BC-81B8-4BB6-8172-35E1C178FA0F

P698

Q34715598-CCF56AF8-0E35-4BC2-A2F2-206229926A17

P921

Q34715598-A9F82C07-0B91-4C56-B93E-3D039BDADAD5

P932

Q34715598-A2122163-C95E-47DF-AFA0-5B9AF754B24F

P356

1078-0432.CCR-14-0900

P1433

Clinical Cancer Research

P1476

New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.

@en

P2093

Ivana Gojo

http://www.w3.org/2001/XMLSchema#string

Judith E Karp

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

Advances in understanding the leukaemia microenvironment

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

6233-6241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-0900

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25324141

http://www.w3.org/2001/XMLSchema#string

P921

P932

4268164

http://www.w3.org/2001/XMLSchema#string